GBI Research has estimated that
the Contract Research
Organisations (CROs) industry will
grow at an annual rate of 12.8% to
US$56 billion by 2018.
“A slower growth rate in turnover
against growth in R&D expenditure
indicates that many companies
struggled to maintain their level of
returns on R&D expenditure,” a
statement from GBI Research said.
“Outsourcing clinical trial
activities to CROs, particularly in
the developing nations, is rapidly
gaining acceptance in the industry,”
GBI added.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Apr 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Apr 12
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.